An update of advanced nanoplatforms for Glioblastoma Multiforme Management

Glioblastoma multiforme (GBM) is a very aggressive and heterogeneous glioma. Currently, GBM is treated with a combination of surgery, radiotherapy, chemotherapy (e.g. temozolamide) and Tumour Treating Fields. Unfortunately, the mean survival is still around 15 months. This poor prognosis is associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Amaral, Mariana, Cruz, Nuno, Rosa, Ana, Nogueira, Beatriz, Costa, Diana, Santos, Francisco, Brazão, Mariana, Policarpo, Pedro, Mateus, Rita, Kobozev, Yan, Reis, Catarina Pinto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Leibniz Research Centre for Working Environment and Human Factors 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678060/
https://www.ncbi.nlm.nih.gov/pubmed/34924904
http://dx.doi.org/10.17179/excli2021-4393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678060/
https://www.ncbi.nlm.nih.gov/pubmed/34924904
http://dx.doi.org/10.17179/excli2021-4393

Ejemplares similares